Skip to main content
Top
Published in: World Journal of Surgery 5/2020

01-05-2020 | Hashimoto Thyroiditis | Original Scientific Report

Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma

Authors: Daixing Hu, Huapeng Lin, Xuan Zeng, Tielin Wang, Jie Deng, Xinliang Su

Published in: World Journal of Surgery | Issue 5/2020

Login to get access

Abstract

Background

Cervical lymph node metastasis is a prognostic factor of papillary thyroid carcinoma (PTC). Skip metastasis (central lymph node negative and lateral lymph node positive) of PTC is not uncommon. This study aimed to retrospectively investigate the risk factors for skip metastasis in PTC and develop a prediction model for skip metastasis.

Methods

A total of 745 PTC patients underwent total thyroidectomy and central plus lateral lymph node dissection at the First Affiliated Hospital of Chongqing Medical University from January 2012 to December 2017. Clinicopathological characteristics were collected and analyzed. Univariate and multivariate analyses were performed to detect the risk factors for skip metastasis. A prediction model was established based on the results of multivariate analyses.

Results

The skip metastasis rate was 9.7% (72/745). Age > 55 years (OR 2.63, 95% CI 1.34–5.04, p = 0.004), tumor located in the upper portion (OR 4.15, 95% CI 2.30–7.63, p = 0.001), and unilaterality (OR 2.76, 95% CI 1.14–8.23, p = 0.040) were independent risk factors for skip metastasis. Clinically lymph node-negative (cN0) patients with tumor in the upper portion (24.6%, 43/175) had higher possibility of skip metastasis than those of clinically lateral lymph node-positive (cN1b) patients (5.9%, 10/169) (p = 0.001). The area under the receiver operating characteristic curve of prediction model was 0.734 and 0.740 in derivation group and validation group, respectively. However, skip metastasis was not associated with tumor-free survival rate of PTC patients (p = 0.274).

Conclusion

Age > 55 years, tumor located in the upper portion, and unilaterality may increase the risk of skip metastasis. We developed the first prediction model for skip metastasis based on clinicopathological parameters in PTC patients.
Literature
1.
go back to reference Davies L, Welch HG (2014) Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 140:317–322CrossRef Davies L, Welch HG (2014) Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 140:317–322CrossRef
2.
go back to reference Leenhardt L, Grosclaude P, Cherie-Challine L (2004) Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid Off J Am Thyroid Assoc 14:1056–1060CrossRef Leenhardt L, Grosclaude P, Cherie-Challine L (2004) Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid Off J Am Thyroid Assoc 14:1056–1060CrossRef
3.
go back to reference Malterling RR, Andersson RE, Falkmer S et al (2010) Differentiated thyroid cancer in a Swedish county—long-term results and quality of life. Acta Oncol (Stockholm, Sweden) 49:454–459CrossRef Malterling RR, Andersson RE, Falkmer S et al (2010) Differentiated thyroid cancer in a Swedish county—long-term results and quality of life. Acta Oncol (Stockholm, Sweden) 49:454–459CrossRef
4.
go back to reference Caron NR, Clark OH (2005) Papillary thyroid cancer: surgical management of lymph node metastases. Curr Treat Options Oncol 6:311–322CrossRef Caron NR, Clark OH (2005) Papillary thyroid cancer: surgical management of lymph node metastases. Curr Treat Options Oncol 6:311–322CrossRef
5.
go back to reference Isaacs JD, McMullen TP, Sidhu SB et al (2010) Predictive value of the Delphian and level VI nodes in papillary thyroid cancer. ANZ J Surg 80:834–838CrossRef Isaacs JD, McMullen TP, Sidhu SB et al (2010) Predictive value of the Delphian and level VI nodes in papillary thyroid cancer. ANZ J Surg 80:834–838CrossRef
6.
go back to reference Podnos YD, Smith D, Wagman LD et al (2005) The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg 71:731–734PubMed Podnos YD, Smith D, Wagman LD et al (2005) The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg 71:731–734PubMed
7.
go back to reference Likhterov I, Reis LL, Urken ML (2017) Central compartment management in patients with papillary thyroid cancer presenting with metastatic disease to the lateral neck: anatomic pathways of lymphatic spread. Head Neck 39:853–859CrossRef Likhterov I, Reis LL, Urken ML (2017) Central compartment management in patients with papillary thyroid cancer presenting with metastatic disease to the lateral neck: anatomic pathways of lymphatic spread. Head Neck 39:853–859CrossRef
8.
go back to reference Lim YC, Koo BS (2012) Predictive factors of skip metastases to lateral neck compartment leaping central neck compartment in papillary thyroid carcinoma. Oral Oncol 48:262–265CrossRef Lim YC, Koo BS (2012) Predictive factors of skip metastases to lateral neck compartment leaping central neck compartment in papillary thyroid carcinoma. Oral Oncol 48:262–265CrossRef
9.
go back to reference Lee YS, Shin SC, Lim YS et al (2014) Tumor location-dependent skip lateral cervical lymph node metastasis in papillary thyroid cancer. Head Neck 36:887–891CrossRef Lee YS, Shin SC, Lim YS et al (2014) Tumor location-dependent skip lateral cervical lymph node metastasis in papillary thyroid cancer. Head Neck 36:887–891CrossRef
11.
go back to reference Nie X, Tan Z, Ge M (2017) Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice. BMC Cancer 17:702CrossRef Nie X, Tan Z, Ge M (2017) Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice. BMC Cancer 17:702CrossRef
12.
go back to reference Hu D, Zhou J, He W et al (2018) Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma. World J Surg Oncol 16:30CrossRef Hu D, Zhou J, He W et al (2018) Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma. World J Surg Oncol 16:30CrossRef
13.
go back to reference Chung YS, Kim JY, Bae JS et al (2009) Lateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissection. Thyroid Off J Am Thyroid Assoc 19:241–246CrossRef Chung YS, Kim JY, Bae JS et al (2009) Lateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissection. Thyroid Off J Am Thyroid Assoc 19:241–246CrossRef
14.
go back to reference Ahn BH, Kim JR, Jeong HC et al (2015) Predictive factors of central lymph node metastasis in papillary thyroid carcinoma. Ann Surg Treat Res 88:63–68CrossRef Ahn BH, Kim JR, Jeong HC et al (2015) Predictive factors of central lymph node metastasis in papillary thyroid carcinoma. Ann Surg Treat Res 88:63–68CrossRef
15.
go back to reference Yan H, Zhou X, Jin H et al (2016) A study on central lymph node metastasis in 543 cN0 papillary thyroid carcinoma patients. Int J Endocrinol 2016:1878194CrossRef Yan H, Zhou X, Jin H et al (2016) A study on central lymph node metastasis in 543 cN0 papillary thyroid carcinoma patients. Int J Endocrinol 2016:1878194CrossRef
16.
go back to reference Kliseska E, Makovac I (2012) Skip metastases in papillary thyroid cancer. Coll Antropol 36(Suppl 2):59–62PubMed Kliseska E, Makovac I (2012) Skip metastases in papillary thyroid cancer. Coll Antropol 36(Suppl 2):59–62PubMed
18.
go back to reference Lei J, Zhong J, Jiang K et al (2017) Skip lateral lymph node metastasis leaping over the central neck compartment in papillary thyroid carcinoma. Oncotarget 8:27022–27033PubMedPubMedCentral Lei J, Zhong J, Jiang K et al (2017) Skip lateral lymph node metastasis leaping over the central neck compartment in papillary thyroid carcinoma. Oncotarget 8:27022–27033PubMedPubMedCentral
20.
go back to reference Machens A, Holzhausen HJ, Dralle H (2004) Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg (Chicago, IL: 1960) 139:43–45 Machens A, Holzhausen HJ, Dralle H (2004) Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg (Chicago, IL: 1960) 139:43–45
21.
go back to reference Koo BS, Choi EC, Park YH et al (2010) Occult contralateral central lymph node metastases in papillary thyroid carcinoma with unilateral lymph node metastasis in the lateral neck. J Am Coll Surg 210:895–900CrossRef Koo BS, Choi EC, Park YH et al (2010) Occult contralateral central lymph node metastases in papillary thyroid carcinoma with unilateral lymph node metastasis in the lateral neck. J Am Coll Surg 210:895–900CrossRef
22.
go back to reference Li H, Hu H, Wang R et al (2015) Lung adenocarcinoma: Are skip N2 metastases different from non-skip? J Thorac Cardiovasc Surg 150:790–795CrossRef Li H, Hu H, Wang R et al (2015) Lung adenocarcinoma: Are skip N2 metastases different from non-skip? J Thorac Cardiovasc Surg 150:790–795CrossRef
23.
go back to reference Bao F, Zhao LY, Balde AI et al (2016) Prognostic impact of lymph node skip metastasis in Stage III colorectal cancer. Colorectal Dis Off J Assoc Coloproctol G B Irel 18:O322–O329 Bao F, Zhao LY, Balde AI et al (2016) Prognostic impact of lymph node skip metastasis in Stage III colorectal cancer. Colorectal Dis Off J Assoc Coloproctol G B Irel 18:O322–O329
Metadata
Title
Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma
Authors
Daixing Hu
Huapeng Lin
Xuan Zeng
Tielin Wang
Jie Deng
Xinliang Su
Publication date
01-05-2020
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 5/2020
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-019-05332-0

Other articles of this Issue 5/2020

World Journal of Surgery 5/2020 Go to the issue